SARS-CoV-2 BA.1 variant is neutralized by vaccine booster-elicited serum but evades most convalescent serum and therapeutic antibodies

Sabrina Lusvarghi, Simon D. Pollett, Sabari Nath Neerukonda, Wei Wang, Richard Wang, Russell Vassell, Nusrat J. Epsi, Anthony C. Fries, Brian K. Agan, David A. Lindholm, Christopher J. Colombo, Rupal Mody, Evan C. Ewers, Tahaniyat Lalani, Anuradha Ganesan, Emilie Goguet, Monique Hollis-Perry, Si'Ana A. Coggins, Mark P. Simons, Leah C. KatzelnickGregory Wang, David R. Tribble, Lisa Bentley, Ann E. Eakin, Christopher C. Broder, Karl J. Erlandson, Eric D. Laing, Timothy H. Burgess, Edward Mitre, Carol D. Weiss*

*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

72 Scopus citations

Fingerprint

Dive into the research topics of 'SARS-CoV-2 BA.1 variant is neutralized by vaccine booster-elicited serum but evades most convalescent serum and therapeutic antibodies'. Together they form a unique fingerprint.

Medicine & Life Sciences